Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Iota Biosciences: Protecting Pioneering Technology

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

MoFo represented iota Biosciences’ (“iota”) from its inception in 2017 and through its acquisition by Astellas Pharma Inc. (“Astellas”) in 2020. Our Life Sciences + Healthcare industry team continues to represent iota post-acquisition, focusing on iota’s overall IP strategy and protecting its pioneering technology.

MoFo represented iota Biosciences’ (“iota”) from its inception in 2017 and through its acquisition by Astellas Pharma Inc. (“Astellas”) in 2020. Our Life Sciences + Healthcare industry team continues to represent iota post-acquisition, focusing on iota’s overall IP strategy and protecting its pioneering technology.

Jon Bockman is the head of the firm’s Technology Patent Practice. In this capacity, he leads the firm’s prominent group of patent practitioners with degrees in electrical engineering, mechanical engineering, computer science, computer engineering, chemical engineering, biomedical engineering and physics. His team handles work in all technology areas including medical devices, AI and machine learning, cybersecurity, computer hardware, advanced materials, and robotics. His practice concentrates on domestic and international patent prosecution, portfolio management, IP due diligence, patent infringement and validity determinations, and IP litigation support. His clients range from some of the largest domestic and international companies to early-stage startups.As lead patent prosecution counsel for several large and emerging companies, Jon has helped clients set up patent departments and committees for building and maintaining strategic patent portfolios. Clients note to IAM Patent 1000 that “[Jon] provides expert legal advice that is clear, understandable and tailored to the needs of the specific client. He is very responsive and is always available when you need him.”Jon has extensive experience helping clients navigate IP concerns including freedom-to-operate and potential litigation issues. Jon is also experienced with leading patent due diligence projects related to investments and mergers and acquisitions. He often leads investor-side and company-side patent due diligence reviews related to these transactions.Jon is a member of the firm’s Inter Partes Review and Post Grant Practice. In this capacity, he handles inter partes review and post-grant review proceedings that were introduced by the Leahy-Smith America Invents Act. He has also handled many disputes for clients in front of the U.S. Patent and Trademark Office (USPTO), including inter partes reexaminations, ex parte reexaminations, and derivation proceedings.Jon is recognized as an IP Star by Managing Intellectual Property and as a leading patent practitioner by IAM Patent 1000. He is also recommended by The Legal 500 US for patent prosecution. While earning his J.D., Jon was the associate editor of the University of Colorado Law Review.

Jonathan Bockman

Partner

Dr. Ethan M. Weiner is of counsel in the firm’s Intellectual Property Group. His practice focuses on patent prosecution, IP due diligence, and patent portfolio management and counseling. Dr. Weiner handles a wide array of technologies, including pharmaceuticals, genomics, nanoparticle technologies, and medical devices.Dr. Weiner received his J.D. from the University of California, Berkeley, School of Law where he was the Senior Articles Editor for the Berkeley Technology Law Journal and won the Prosser Prize for Patent Prosecution. Prior to law school, he received his Ph.D. in biochemistry and molecular biology from the University of California, Los Angeles, where his doctoral research focused on biomolecule structure, protein dynamics, and protein-small molecule interactions.

Ethan Weiner

Of Counsel

Life Sciences + Healthcare

MedTech